Jade Biosciences, Inc. Common Stock JBIO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$129.61M-27.0% | -$127.41M-46.4% | -$142.46M-136% | -$133.56M-109% | -$102.02M-24.1% | ||
| $31K-88.0% | $26K-90.8% | $25K-91.7% | $231K+112% | $258K+150% | ||
| $24.99M+230% | $20.01M+114% | $11.87M+4.6% | $7.6M-47.8% | $7.57M-44.8% | ||
| -$100.01M-108% | -$94.69M-78.4% | -$83.65M-84.8% | -$68.33M-26.3% | -$48.17M+30.2% | ||
| —— | $196K— | —— | —— | —— | ||
| -$268.33M-1,133% | -$247.01M-1,225% | -$135.72M-1,037% | $12.99M— | $25.98M— | ||
| $360.67M+93.8% | $360.77M+92.7% | $282.61M+195% | $377.38M+39,458% | $186.07M+302% | ||
| $5.16M-96.3% | $19.05M-86.7% | $50.11M— | $308.91M— | $137.9M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jade Biosciences, Inc. Common Stock generate?
- Jade Biosciences, Inc. Common Stock (JBIO) generated -$100.0M in operating cash flow over the trailing twelve months.
- What is Jade Biosciences, Inc. Common Stock's free cash flow?
- After $196.0K of capital expenditures, Jade Biosciences, Inc. Common Stock's free cash flow was -$94.9M over the trailing twelve months, down 66.7% year over year.
- Where does Jade Biosciences, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Jade Biosciences, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.